Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.
Also called NCT06767774
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,000 participants
- Sponsor
- Registry
-
NCT06767774
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06767774. Randomized; no masking; primary purpose prevention. Start 2025-04-25 (actual); primary completion 2029-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
- Condition
- ASCVD
- Condition
- Diabetes
- Condition
- Statin
- Intervention (Drug)
- Combination therapy
- Intervention (Drug)
- High intensity statin monotherapy
- Lead sponsor
- Korea University Anam Hospital
- Collaborator
- Daewon Pharmaceutical Co., Ltd.
- Collaborator
- Samjin Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct06767774- Content hash
d20e1a7a3d5a80981ea7c28520d971a26964ef88b1be31bddd9c57c3592e766c